Table 3. RIF Pretreatment X RIF Pos Treatment : Cytometric Parametres
|
Cytometric Parametres
|
RIF Pretreatment
|
RIF Postreatment
|
P
|
LBR+
|
Endometrial thickness (mm)
|
8.8±2(6-13)
|
9.64±2.18(6-13)
|
NS
|
Anormal pathology |
8/16 (50)
|
1/16 (6.2)
|
0.0031
|
CFE |
|
|
|
Li/PC |
18.18±8.3(6-32)
|
6.91±4.67(2-16)
|
0.0045
|
LT/Li |
48.64±20.4(16-71)
|
52.55±14(38-69)
|
NS
|
LB/Li |
1.64±1.5(0-5)
|
1.45±2.16(0-5)
|
NS
|
NK/Li |
46.73±21.87(22-82)
|
36.55±13.9(15-57)
|
0.078
|
CD3+CD4/LTCD3+ |
49.40±9.83(33-64)
|
47±7.9(38-65)
|
NS
|
CD3+CD8/LTCD3+ |
50.64±9.3(36-67)
|
52.18±7.75(35-62)
|
NS
|
CD4/CD8 |
1.04±0.39(0.49-1.77)
|
0.94±0.35(0.6-1.8)
|
NS
|
NK CD56dimCD16bright |
17.56±12.7(5-39)
|
19.5±11.9(7-44)
|
NS
|
NKCD56brightCD16dim |
80.22±14.66(53-95)
|
78.5±12.69(55-93)
|
NS
|
LBR- |
Endometrial thickness (mm) |
8.4±2.3(6-12)
|
9.3±1.7(8-13)
|
NS
|
Anormal pathology |
8/14 (57.1)
|
4/14 (28.57)
|
NS
|
CFE |
|
|
|
Li/PC |
15.57±6.52(4-26)
|
6.85±3.89(3-15)
|
0.03
|
LT/Li |
47.85±11.29(36-65)
|
41.57±14.79(22-69)
|
NS
|
LB/Li |
5.42±4.79(0-11)
|
2.57±1.39(1-4)
|
NS
|
NK/Li |
40.42±15.70(20-62)
|
55±13.8(30-75)
|
0.045
|
CD3+CD4/LTCD3+ |
42.71±15.27(20-65)
|
44±8.48(35-55)
|
NS
|
CD3+CD8/LTCD3+ |
55.28±14.12(35-80)
|
54±6.45(45-63)
|
NS
|
CD4/CD8 |
0.88±0.53(0.25-1.85)
|
0.88±0.26(0.59-1.22)
|
NS
|
NK CD56dimCD16bright |
12.42±16.0(3-48)
|
11.71±4.34(7-20)
|
NS
|
NKCD56brightCD16dim
|
85.28±19.98(41-97)
|
86.42±7.04(72-93)
|
NS
|